In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G stannous fluoride analysis suggested as gingivitis efficacy model by plaque subcmte.

This article was originally published in The Rose Sheet

Executive Summary

P&G FLUORIDE ANALYSIS AS "MODUS OPERANDI" SUGGESTED BY PLAQUE SUBCMTE. for other companies to follow in the quest to prove ingredient efficacy for plaque, gingivitis and gingival bleeding claims. Procter & Gamble's analyses of the efficacy of stannous fluoride at the Dec. 16-17 meeting of the Dental Product Panel's Plaque Subcommittee may serve as an "umbrella" model that, "while not definitive for every product," may provide "a general modus operandi" for other ingredients seeking to claim prevention and reduction of gingivitis, Subcommittee Chair Robert Genco, PhD, SUNY-Buffalo School of Medicine, said.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts